Prognostic Value of Baseline High-Uptake PSMA Tumor Volume Fraction in Metastatic Castration-Resistant Prostate Cancer Patients Treated with [(177)Lu]Lu-PSMA Radioligand Therapy.
Cuzzocrea M, Pecoraro G, Iacovitti CM, Martinello C, Treglia G, Gillessen S, Pedrani M, Paone G
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.